Advances in secondary prevention: Optimising cardiometabolic risks
Sponsorship of this congress is initiated, developed and funded by © Amarin Pharmaceuticals Ireland Limited
This session will delve into evidence-based approaches to managing secondary prevention in cardiovascular disease, empowering primary care providers to reduce CV risk and improve long-term patient health.